Ascendis Pharma A/S — All Filings
742 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
144
144/A
20-F
3
424B4
424B5
6-K
6-K/A
8-A12B
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-3ASR
F-3MEF
F-6
FWP
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 6-K | 6-K | 0001193125-26-121795 | Mar 24, 2026 | — |
| 3 | — | 0001610717-26-000119 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000118 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000117 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000116 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000115 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000114 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000113 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000112 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000111 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000110 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000109 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000108 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000107 | Mar 18, 2026 | — |
| 3 | — | 0001610717-26-000106 | Mar 18, 2026 | — |
| 6-K | 6-K | 0001193125-26-110751 | Mar 17, 2026 | — |
| 6-K | 6-K | 0001193125-26-108327 | Mar 16, 2026 | — |
| 6-K | 6-K | 0001193125-26-102117 | Mar 11, 2026 | — |
| 144 | — | 0001964306-26-000166 | Mar 9, 2026 | — |
| 144 | — | 0001964306-26-000155 | Mar 6, 2026 | — |
| 144/A | — | 0001964306-26-000153 | Mar 6, 2026 | — |
| 144 | — | 0001964306-26-000151 | Mar 5, 2026 | — |
| 144 | — | 0001964306-26-000150 | Mar 5, 2026 | — |
| 144 | — | 0001968582-26-000231 | Mar 5, 2026 | — |
| 144 | — | 0001964306-26-000147 | Mar 4, 2026 | — |
| 144 | — | 0001973379-26-000078 | Mar 4, 2026 | — |
| 144 | — | 0001973379-26-000065 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000064 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000063 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000062 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000061 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000060 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000059 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000058 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000057 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000056 | Mar 2, 2026 | — |
| 144 | — | 0001973379-26-000055 | Mar 2, 2026 | — |
| 6-K | 6-K | 0001193125-26-084021 | Mar 2, 2026 | Feb 28, 2026 |
| S-8 | S-8 | 0001193125-26-082509 | Feb 27, 2026 | — |
| 6-K | 6-K | 0001193125-26-063954 | Feb 23, 2026 | — |
| 6-K | 6-K | 0001193125-26-046736 | Feb 11, 2026 | — |
| 20-F | 20-F | 0001193125-26-046590 | Feb 11, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | — | 0001177719-26-000008 | Feb 11, 2026 | — |
| 6-K | 6-K | 0001193125-26-045434 | Feb 11, 2026 | Feb 10, 2026 |
| SCHEDULE 13G/A | — | 0001193125-26-035094 | Feb 3, 2026 | — |
| 6-K | 6-K | 0001193125-26-012936 | Jan 14, 2026 | — |
| 144 | — | 0001973379-26-000011 | Jan 13, 2026 | — |
| 6-K | 6-K | 0001193125-26-009636 | Jan 12, 2026 | — |
| 6-K | 6-K | 0001193125-26-007934 | Jan 9, 2026 | Jan 8, 2026 |
| 6-K | 6-K | 0001193125-25-337124 | Dec 30, 2025 | — |